scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.69.1.1 |
P698 | PubMed publication ID | 6689632 |
P2093 | author name string | E Weihe | |
G Mall | |||
W Kübler | |||
F Schwarz | |||
J Manthey | |||
D Opherk | |||
H Zebe | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | arterial hypertension | Q41861 |
P304 | page(s) | 1-7 | |
P577 | publication date | 1984-01-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries | |
P478 | volume | 69 |
Q93649158 | Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms |
Q52275734 | An assessment of the distortion of arteries due to sectioning in endomyocardial biopsies. |
Q34986413 | An updated concept for left ventricular hypertrophy risk in hypertension |
Q39470341 | Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia |
Q73782365 | Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy |
Q41500182 | Cardiac effects of calcium antagonists in systemic hypertension |
Q64246295 | Characteristics of coronary artery disease in chronic kidney disease |
Q50906480 | Clinical and angiographic findings in black patients with suspected coronary artery disease. |
Q41404103 | Clinical application of coronary flow reserve using an intracoronary Doppler guide wire |
Q90405124 | Clinical care for patients with recurrent myocardial ischemia in Germany-the VOICES trial |
Q33729553 | Clinical correlation between N-terminal pro-B-type natriuretic peptide and angiographic coronary atherosclerosis |
Q39309127 | Comparative study of coronary flow reserve, coronary anatomy and results of radionuclide exercise tests in patients with coronary artery disease |
Q73744496 | Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina |
Q71270580 | Comparison of relation of systolic flow of the right coronary artery to pulmonary artery pressure in patients with and without pulmonary hypertension |
Q40380091 | Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat |
Q83924432 | Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease |
Q46435792 | Coronary angiographic findings in African-American and white patients from a single institution |
Q58106412 | Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy |
Q88551207 | Coronary artery-left ventricular shunt: an important cause of chest pain in patients with hypertrophic cardiomyopathy |
Q34118190 | Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia |
Q68409435 | Coronary flow reserve as a physiologic measure of stenosis severity |
Q73226887 | Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study |
Q35376387 | Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study |
Q36830689 | Coronary haemodynamics in left ventricular hypertrophy |
Q46079498 | Diastolic regional wall motion asynchrony in patients with hypertension |
Q27001759 | Differences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysis |
Q72189531 | Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension |
Q54376748 | Effects of vasodilators on the coronary circulation in congestive heart failure. |
Q54112242 | Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. |
Q61650837 | Homogeneously Reduced Versus Regionally Impaired Myocardial Blood Flow in Hypertensive Patients: Two Different Patterns of Myocardial Perfusion Associated With Degree of Hypertrophy |
Q38369509 | Hypertension and left ventricular diastolic function |
Q67898638 | Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease |
Q48300541 | Impaired coronary flow reserve in obstructive sleep apnea and its improvement after continuous positive airway pressure therapy: a transthoracic Doppler echocardiographic study. |
Q39287517 | Impaired myocardial perfusion in patients with hypertrophic cardiomyopathy: assessment with digital subtraction coronary arteriography |
Q73708507 | Intravascular ultrasound findings in patients with abnormal coronary flow reserve after stenting |
Q68419569 | Iodine-123 phenylpentadecanoic acid myocardial scintigraphy in patients with left ventricular hypertrophy: alterations in left ventricular distribution and utilization |
Q36894457 | Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation |
Q43693241 | Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance |
Q35047681 | Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy |
Q54470079 | Management of patients with hypertension and angina pectoris. |
Q54302622 | Mechanisms of angina pectoris in syndrome X. |
Q36495359 | Medical Therapy of the Hypertensive Patient with Concomitant Angina Pectoris |
Q45175183 | Microcirculation in the hypertrophic and ischemic heart |
Q72546743 | Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy |
Q35093085 | Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management |
Q73010879 | Microvascular disease--the Cinderella of uraemic heart disease |
Q51824398 | Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. |
Q83870576 | Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease |
Q34658325 | Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application |
Q35375028 | Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms |
Q34333664 | Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography. |
Q72827369 | Potassium and the heart |
Q71550233 | Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography |
Q46621456 | Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients |
Q35166936 | Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy |
Q33586708 | Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives? |
Q46634183 | Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. |
Q52423069 | Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease |
Q77700083 | Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery |
Q73746088 | Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus |
Q39613149 | Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina |
Q74831159 | Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension |
Q71711873 | Sudden cardiac death |
Q69152697 | Syndrome X |
Q43996819 | Syndrome X revisited |
Q60647431 | Systemic hypertension and coronary artery disease: the link |
Q40380084 | Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease |
Q35660829 | Target organ involvement in hypertension: a realistic promise of prevention and reversal |
Q37514842 | The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation |
Q54041396 | The influence of left ventricular geometry on coronary vasomotion in patients with essential hypertension. |
Q33768923 | The necessity for recognition and treatment of patients with "mild" hypertension |
Q33367466 | The puzzle of normal coronary arteries in the patient with chest pain: what to do? |
Q73272376 | Three-dimensional reconstruction of abnormal intramural coronary arteries in human cardiac allograft biopsies |
Q34173260 | Transesophageal echocardiography (TEE) in the evaluation of the coronary arteries |
Q30535399 | Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy |
Q72100332 | Usefulness of simultaneous ambulatory electrocardiographic and blood pressure monitoring in detecting myocardial ischemia in patients >70 years of age with systemic hypertension |
Q43738902 | Validation in the canine model of a new non-invasive method of measuring coronary blood flow reserve: split dose thallium-201 rest/stress imaging |
Q95466251 | [Arterial hypertension in patients with coronary artery disease] |
Search more.